Standout Papers

Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal ... 2007 2026 2013 2019 517
  1. Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets (2007)
    Uwe Rix, Oliver Hantschel et al. Blood

Immediate Impact

3 by Nobel laureates 27 from Science/Nature 57 standout
Sub-graph 1 of 22

Citing Papers

Principles and therapeutic applications of adaptive immunity
2024 Standout
Computational approaches streamlining drug discovery
2023 StandoutNature
6 intermediate papers

Works of Ines Kaupe being referenced

BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia
2012
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets
2007 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Ines Kaupe 574 404 234 589 13 1.2k
Janis Liebetanz 396 267 157 966 11 1.6k
M. Gorre 544 497 283 439 28 1.3k
Chester A. Metcalf 291 197 148 638 28 1.2k
J Y Wang 616 365 159 754 12 1.3k
Mohammad Azam 842 656 361 689 35 1.6k
Francisco Adrián 401 266 91 701 30 1.6k
Derek Norris 1001 720 488 464 19 1.7k
Ping Chen 1143 735 492 532 23 1.6k
Steffen Klippel 600 316 116 678 27 1.2k
Ophelia Rogers 389 494 215 684 33 1.1k

All Works

Loading papers...

Rankless by CCL
2026